Figure 2
Prognostic impact of cohesin mutations in all investigated AML patients. (A) OS in AML patients with wild-type (WT) or mutated genes of the cohesin complex. (B) RFS in AML patients with WT or mutated genes of the cohesin complex.
Prognostic impact of cohesin mutations in all investigated AML patients. (A) OS in AML patients with wild-type (WT) or mutated genes of the cohesin complex. (B) RFS in AML patients with WT or mutated genes of the cohesin complex.
